Innovating Works

H2020

Cerrada
HORIZON-HLTH-2021-TOOL-06-02
Next generation advanced therapies to treat highly prevalent and high burden diseases with unmet medical needs
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 5 “Unlocking the full potential of new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim for delivering results that are directed, tailored and contributing to all of the following expected outcomes:
Sólo fondo perdido 100%
Europeo
Mostrando 21 al 40 de 49 resultados
EU NAVIGATE: Implementation and evaluation of a Navigation Intervention for People with Cancer in Old Age and the... VRIJE UNIVERSITEIT BRUSSEL tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Background: Most people who have cancer are older people, affecting millions of Europeans each year. Providing high-quality, equitable, and...
2022-05-24 - 2027-08-31 | Financiado
LiverTarget: Next generation advanced RNA inhibition therapy to treat cardiometabolic disease TAMPEREEN KORKEAKOULUSAATIO SR tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 RNA Therapeutics comprise a new rapidly expanding category of drugs including small interfering RNAs (siRNA) and messenger RNAs (mRNA) that...
2022-05-24 - 2027-04-30 | Financiado
INSPIRE: Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delive... MYRIAD CONSULTING LIMITED tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 Lung cancer (LC) treatments have advanced in recent years with the advent of genetic profiling and immunotherapy. However, LC is a complex h...
2022-05-24 - 2025-05-31 | Financiado
geneTIGA: Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome edit... CHARITE UNIVERSITAETSMEDIZIN BERLIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 "There is an increasing prevalence of chronic diseases caused by undesired immune reactions (>10%) with high burden for the both patients (c...
2022-05-23 - 2026-06-30 | Financiado
Long Covid: Decision support for prediction and management of Long Covid Syndrome (LCS) HUSYHTYMA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 We will develop tools and knowledge to support physicians in accurately managing Long COVID syndrome (LCS) which has a significant impact on...
2022-05-23 - 2026-05-31 | Financiado
HEAL: HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to... MEDIZINISCHE HOCHSCHULE HANNOVER tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 HEAL will focus on general bottlenecks to induced pluripotent stem cell therapies with a particular focus on heart failure, which remains a...
2022-05-23 - 2026-02-28 | Financiado
EPIVINF: Epigenetic regulation of host factors in viral infections EPIVINF FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 The EPIVINF project aims to gain a deep understanding of how acute viral infections alter the epigenetic regulation of host factors that are...
2022-05-23 - 2027-08-31 | Financiado
VECTOR: Vectors to Accessible Critical Raw Material Resources in Sedimentary Basins HELMHOLTZZENTRUM DRESDENROSSENDORF EV tramitó un HORIZON EUROPE: HORIZON-CL4-2021-RESILIENCE-01 The EU imports 80% of its industrial raw materials making European supply chains highly vulnerable to disruption and threatening the EU's ab...
2022-05-22 - 2025-05-31 | Financiado
PAINLESS: Pain relief in palliative care of cancer using home based neuromodulation and predictive biomarkers UNIVERSIDAD DE SANTIAGO DE COMPOSTELA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 More than 50% of cancer patients develop pain before death: 80% can be treated with drugs, but 20% show a low response or have serious adver...
2022-05-20 - 2027-05-31 | Financiado
NEUROCOV: The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV BUNDESMINISTERIUM FUER GESUNDHEIT tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 The COVID19 pandemic has shown our health care fragility vis a vis novel pathogens, with a global disruption on societal welfare. Despite th...
2022-05-20 - 2027-08-31 | Financiado
SEMACRET: Sustainable exploration for orthomagmatic (critical) raw materials in the EU: Charting the road to t... OULUN YLIOPISTO tramitó un HORIZON EUROPE: HORIZON-CL4-2021-RESILIENCE-01 Critical raw materials (CRMs) are fundamental to the EU industrial value chains and strategic sectors, particularly with regard to the green...
2022-05-20 - 2025-05-31 | Financiado
UNDINE: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infect... AARHUS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "The consequences of SARS-CoV-2 exposure range from a lack of infection to lethal COVID-19. This immense inter-individual clinical variabili...
2022-05-20 - 2026-05-31 | Financiado
MyPath: Developing and implementing innovative Patient Centred Care Pathways for cancer patients Innovasjon Norge tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 In the EU, 2.7M people were diagnosed with and 1.3M died of cancer in 2020. Over 12M people have survived cancer, thanks to advances in earl...
2022-05-20 - 2027-08-31 | Financiado
EuReComp: European recycling and circularity in large composite components ETHNICON METSOVION POLYTECHNION tramitó un HORIZON EUROPE: HORIZON-CL4-2021-RESILIENCE-01 EUReCOMP aims to provide sustainable methods towards recycling and reuse of composite materials, coming from components used in various indu...
2022-05-20 - 2026-03-31 | Financiado
GENEGUT: Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 Crohn’s disease is a non-communicable, global disease with an accelerating incidence (up to 23 per 100,000 persons/year) and annual health c...
2022-05-19 - 2026-09-30 | Financiado
SINPAIN: A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to tr... FUNDACION CIDETEC tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 According to the WHO Osteoarthritis (OA) is one major course of years lived with disability in the elderly and considered a high burden dise...
2022-05-19 - 2026-10-31 | Financiado
CANCERNA: RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY HADASSAH MEDICAL ORGANIZATION tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 In the past five years, RNA therapeutics have witnessed a true revolution. Several RNA-based therapies have been approved for the treatment...
2022-05-19 - 2025-05-31 | Financiado
PAL-CYCLES: PALliative Care Yields Cancer welLbEing Support STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Challenge: many patients with advanced cancer in the final phase of life leave the hospital without continuity of information, and certainty...
2022-05-18 - 2027-08-31 | Financiado
4.UNCAN.eu: A Coordination and Support Action to prepare UNCAN.eu platform INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-MISS-2021-UNCAN-01 The 15-month coordination and support action 4.UNCAN.eu will generate a strategic agenda to launch UNCAN.eu, a European initiative to UNders...
2022-05-17 - 2023-11-30 | Financiado
MC4: Multi-level Circular Process Chain for Carbon and Glass Fibre Composites PROFACTOR GMBH tramitó un HORIZON EUROPE: HORIZON-CL4-2021-RESILIENCE-01 Each year about 110.000t of carbon fibre composite parts and 4.500.000t of glass fibre composites are used. 98% of these parts end up in lan...
2022-05-16 - 2025-03-31 | Financiado